Become a donor or member and support our work to advance access to medicines. For everyone. Everywhere
2023
2022
Licensing of health technologies: New Report
WTO institutionally unfit for the purpose of delivering sustainable solutions
Introducing the TRIPS Flexibilities Navigator
HAI Statement on Tentative Agreement on TRIPS and COVID-19
2021
Getting Hack to Reality
A Pandemic Response Lacking Moral Leadership
MPs and MEPs Call for TRIPS Waiver
Challenging the IP Protection Framework
Over 100 MEPs call for a TRIPS Waiver
2020
HAI’s Great Health Hack Delivers Great Ideas for Access to Meds
Europe Faces a Critical Time of Key Medicine Shortages Amidst a Pandemic
EU Must Not Miss its Chance on WHO Technology Pool
TRIPS-flexibilities in Health Crises and Beyond
2019
A Momentous Week for Access to Medicines
2018
Staff Spotlight: Jaume Vidal
Medicijnen: de link met de maatschappij
Open Science for Health: Shaping the New Framework Programme
2017
EU-Mercosur Trade Agreement: A bad deal for transparency, policy coherence and access to medicines
New Dutch Government Must Ensure Transparency to Control Medicine Prices
Staff Spotlight: Tim Reed
2016
Next Gen Advocates Excel at HAI/HP4L Summer School on Access to Medicines
‘Achieiving Affordable Access to Health Technologies’ Side Event at WHA69
2015
Successful week of advocacy for HAI delegation at 68th World Health Assembly
The EU-US Trade Deal Could Leave Europeans Sick
2014
Democracy violation: European Commission rejects citizens’ initiative to stop TTIP and CETA
Governments must ensure Big Pharma’s expansion in Africa doesn’t impede generics supply
Bayer CEO's callous comments highlight failure of current biomedical innovation model
2010